Similar Papers

Paper Title
Journal
Date
Author
Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: a plain language summary.
Amaal J Starling ... Thomas Brevig
Pain management | VOL. 13
Amaal J Starling, et. al.Amaal J Starling ... Thomas Brevig
01 Jun 2023
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
Michael J Marmura ... Merle L Diamond
Headache: The Journal of Head and Face Pain | VOL. 61
Michael J Marmura, et. al.Michael J Marmura ... Merle L Diamond
22 Sep 2021
Migraine
K Poply ... V Mehta
BJA Education | VOL. 16
K Poply, et. al.K Poply ... V Mehta
01 Nov 2016
To the Editor
Alexander Mauskop
Journal of Pain | VOL. 5
Alexander MauskopAlexander Mauskop
01 Mar 2004
View more papers

More From: Neurology

Paper Title
Journal
Date
Author
Reader Response: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Calixto Machado
Neurology | VOL. -
Calixto MachadoCalixto Machado
28 Jan 2025
Brain Hypertrophy in Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis and Its Clinical Correlates
Richard Zubal ... Marian Galovic
Neurology | VOL. 104
Richard Zubal, et. al.Richard Zubal ... Marian Galovic
28 Jan 2025
Reader Response: Wall-Eyed Bilateral Internuclear Ophthalmoplegia Variant Syndrome Caused by Isolated Left Thalamic Infarction.
Eric R Eggenberger
Neurology | VOL. 104
Eric R EggenbergerEric R Eggenberger
28 Jan 2025
Editors' Note: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Aravind Ganesh ... Steven L Galetta
Neurology | VOL. -
Aravind Ganesh, et. al.Aravind Ganesh ... Steven L Galetta
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.